DI
NVAX icon

DAGCO Inc’s Novavax NVAX Stock Holding History

DAGCO Inc’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-120
Closed -$576 – 334
2023
Q4 		$576 Buy
+120
New +$735 ﹤0.01% 244

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

DAGCO Inc's NVAX Position: Q1 2024 in Review

DAGCO Inc sold out of Novavax (NVAX) in Q1 2024, closing a stake of 120 shares — an estimated $576 sold.

DAGCO Inc first reported a position in NVAX in Q4 2023 and held it in 1 quarter. The position peaked at $576 in Q4 2023. 201 funds tracked by Wall St. Rank hold NVAX as of Q1 2024.

  • DAGCO Inc reported no remaining Novavax position as of Q1 2024 after selling out during the quarter.
  • DAGCO Inc sold 120 Novavax shares in Q1 2024, an estimated $576.
  • DAGCO Inc first reported a position in Novavax in Q4 2023 and held it in 1 quarter.
  • DAGCO Inc's Novavax position peaked at $576 in Q4 2023.
  • 201 funds tracked by Wall St. Rank held Novavax as of Q1 2024.

Based on DAGCO Inc's 13F filing for Q1 2024, filed 15 May 2024.